1. Home
  2. KLTOW vs JFIN Comparison

KLTOW vs JFIN Comparison

Compare KLTOW & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • JFIN
  • Stock Information
  • Founded
  • KLTOW N/A
  • JFIN 2011
  • Country
  • KLTOW United States
  • JFIN China
  • Employees
  • KLTOW 3
  • JFIN N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • JFIN Finance: Consumer Services
  • Sector
  • KLTOW Health Care
  • JFIN Finance
  • Exchange
  • KLTOW Nasdaq
  • JFIN Nasdaq
  • Market Cap
  • KLTOW N/A
  • JFIN 969.7M
  • IPO Year
  • KLTOW 2022
  • JFIN 2019
  • Fundamental
  • Price
  • KLTOW $0.41
  • JFIN $15.83
  • Analyst Decision
  • KLTOW
  • JFIN
  • Analyst Count
  • KLTOW 0
  • JFIN 0
  • Target Price
  • KLTOW N/A
  • JFIN N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • JFIN 244.9K
  • Earning Date
  • KLTOW N/A
  • JFIN 06-04-2025
  • Dividend Yield
  • KLTOW N/A
  • JFIN 3.13%
  • EPS Growth
  • KLTOW N/A
  • JFIN 2.88
  • EPS
  • KLTOW N/A
  • JFIN 3.43
  • Revenue
  • KLTOW N/A
  • JFIN $840,800,386.00
  • Revenue This Year
  • KLTOW N/A
  • JFIN N/A
  • Revenue Next Year
  • KLTOW N/A
  • JFIN N/A
  • P/E Ratio
  • KLTOW N/A
  • JFIN $4.62
  • Revenue Growth
  • KLTOW N/A
  • JFIN 4.83
  • 52 Week Low
  • KLTOW N/A
  • JFIN $4.00
  • 52 Week High
  • KLTOW N/A
  • JFIN $19.23
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • JFIN 51.87
  • Support Level
  • KLTOW N/A
  • JFIN $17.25
  • Resistance Level
  • KLTOW N/A
  • JFIN $19.23
  • Average True Range (ATR)
  • KLTOW 0.00
  • JFIN 1.29
  • MACD
  • KLTOW 0.00
  • JFIN -0.18
  • Stochastic Oscillator
  • KLTOW 0.00
  • JFIN 34.99

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

Share on Social Networks: